MyAML™ is a CLIA- and CAP-validated next generation sequencing assay which identifies clinically actionable, pathogenic, and potentially pathogenic mutations in 194 genes associated with acute myeloid leukemia (AML). MyAML identifies single nucleotide variants (SNVs), insertion-deletion variants (indels) and the entire range of structural variants, including partial tandem duplications (PTDs) and translocations - even those involving novel fusion gene partners. Coupling comprehensive gene coverage with enhanced depth of coverage, long read lengths, and the power of Genection's proprietary MyInformatics™ bioinformatics and annotation database, MyAML identifies the underlying somatic mutations that are present in as low as 5% allelic frequency. Test results, including variants recommended in the NCCN guidelines, are provided in an easy to understand report.

Diagnostic Medical Biological Laboratories Diagnostic Blood Analysis Laboratories Cytology Health Laboratories Dna Testing Laboratories Medical Genetic Testing Laboratories Laboratories

Medical Laboratory Testing Services Medical Medical Laboratories Medical Pathology Laboratories Pathological Analysis Laboratories Pathology Laboratories Medical Testing Laboratories

Contact:	858-224-6666
Address:	6330 Nancy Ridge Dr Ste 106 San Diego, California   92121-3230 , USA
Url:	http://www.genection.com
Year Established:	2012